Accolade® TMZF® Hip Stem Outcomes Study

NCT00957658 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 241

Last updated 2017-08-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate clinical and radiographic outcome data in patients implanted with the Accolade® TMZF® femoral stem.

Conditions

  • Arthroplasty, Replacement, Hip

Interventions

DEVICE

Accolade® TMZF® Hip Stem

Accolade® TMZF® Hip Stem

Sponsors & Collaborators

  • Stryker Orthopaedics

    lead INDUSTRY

Principal Investigators

  • Robert Krushell, MD · Baystate Medical Center

  • Carlton Savory, MD · Hughston Sports Medicine Center

  • Robert Zann, MD · Boca Raton Community Hospital

  • Steven Gausewitz, MD · Hoag Hospital

  • R. Scott Oliver, MD · Jordan Hospital

  • Mary O'Connor, MD · Mayo Clinic

  • Anthony Sanchez, MD · Spartanburg Regional Health Service District, Inc

  • Mark Visk, MD · Spartanburg Regional Health Service District, Inc

  • Steven Teeny, MD · St. Clare Hospital

  • Alan Valadie, MD · Coastal Orthopedics and Sports Medicine

  • Steven Zelicof, MD · Sound Shore Medical Center of Westchester

  • James Bates, MD · Alvarado Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2011-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00957658 on ClinicalTrials.gov